A multicenter, prospective, real-world clinical study to explore rapid assessment of risk stratification in patients with acute upper gastrointestinal bleeding in China

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900028676

Enrollment

Unknown

Registered

2019-12-30

Start date

2020-03-01

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper gastrointestinal bleeding

Interventions

Case series:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 150 Years

Inclusion criteria

Inclusion criteria: 1. Subjects had been diagnosed with upper gastrointestinal bleeding by clinical physicians; 2. Men or women aged >=18 years old; 3. Ethical requirements are met, able and willing to provide written informed consent and to comply with the study.

Exclusion criteria

Exclusion criteria: 1. Acute upper gastrointestinal bleeding combinate with lower gastrointestinal bleeding; 2. Upper gastrointestinal bleeding caused by mechanical injury or other trauma; 3. The patient refused to perform endoscopy; 4. Patients who are participating in ongoing clinical studies of other drugs.

Design outcomes

Primary

Measure	Time frame
Blood pressure;Heart rate;hemoglobin;creatinine;Urea nitrogen;Endoscopic findings;mortality in 90 days;	—

Secondary

Measure	Time frame
rebleeding rate in 72 hours;Rebleeding rate during hospitalization;Total hospital expenses;Rebleeding rate in 90 days;	—

Countries

China

Contacts

Public ContactXuezhong Yu

Peking Union Medical College Hospital

yxzpumch@126.com+86 13601262164

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026